On May 12, the U.S. Food and Drug Administration (FDA) approved VEOZAHTM (Fezolinetant), 45 mg once daily for the treatment of moderate…
ChemRobotics Pvt. Ltd. © 2023, All Rights Reserved.
Designed and Developed by Ample eBusiness
Tag:
treatment
-
-
CompaniesCovid DrugsPfizer
Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
by adminby adminSummary : Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the companies have submitted an application to the U.S. Food…
-
AstraZenecaRegulatoryU.S FDA
FDA says no to AZ’s Fasenra for nasal polyp indication
by adminby adminSummary : AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic…
-
Pharma Science & ResearchRoche
Roche’s Vabysmo to offer ‘fierce competition’ to Regeneron’s Eylea
by adminby adminSummary : Roche’s Vabysmo is having a strong start with doctors, but it has a long way to go if it wants…
-
GileadRegulatoryU.S FDA
FDA Rejects Gilead’s Long-Acting HIV Drug Over Vial Issues
by adminby adminSummary : The U.S. Food and Drug Administration issued a Complete Response Letter (CRL) to Gilead Sciences rejecting its New Drug Application…
-
Global MarketPharma Science & Research
First study to show waning effectiveness of 3rd dose of mRNA vaccines
by adminby adminSummary : A nationwide study from the U.S. Centers for Disease Control and Prevention (CDC) is the first to show that immunity…
-
GileadGlobal MarketPatentsRegulatory
Gilead’s Strong Financials Marred by $1.25B ViiV Patent Settlement
by adminby adminSummary : This week, Gilead Sciences took a $1.25 billion hit after reaching a settlement with ViiV Healthcare on a patent dispute…
-
CompaniesPfizerPharma Science & Research
Pfizer Abandons Ionis’ Cardiovascular and High Triglyceride Program
by adminby adminSummary : Pfizer and Ionis Pharmaceuticals announced that the former is abandoning its vupanorsen program for cardiovascular (CV) risk reduction and severe…
-
Summary : Glenmark Pharmaceuticals on Friday said its US-based unit has received approval from the US health regulator to market Metronidazole Vaginal…
-
CompaniesNovartisRegulatoryU.S FDA
Novartis Cosentyx® Receives FDA Approval for the Treatment of Children and Adolescents with Enthesitis-Related Arthritis and Psoriatic Arthritis
by adminby adminSummary : -New approvals are based on JUNIPERA trial data showing Cosentyx® (secukinumab) demonstrated reduced flare risk versus placebo and improvement in…
Newer Posts